Darryl Sleep on Collaboration and Partnership Across the Entire HHT Community: Patients Can’t Wait!
Darryl Sleep, Former Head Global Public Health at Amgen, BioPharma Executive, reposted from Azmi Nabulsi on LinkedIn:
”I am honored to be part of a dedicated team committed to developing focused, targeted therapeutics to address significant unmet medical need patients living with HHT.
The collaboration and partnership across the entire HHT community of researchers, academics, patient advocacy, patients and caregivers is truly inspiring.
All stakeholders work together with urgency and a deep commitment to improve the lives patients living with HHT.
Patients can’t wait!”
Quoting Azmi Nabulsi‘s post:
”It’s a proud moment for our team to see the engasertib data published in The New England Journal of Medicine.
This recognition validates the strength of the science, the rigor behind the work, and the potential impact for the HHT community.
Thank you to our team, our investigators, and the patients who made this possible.
We now move into the next phase with clarity and confidence as we advance toward our Phase 3 study in 2026.”
Stay updated with Hemostasis Today.
-
Mar 9, 2026, 16:51Melanie Daniel: Exploring Bleeding Complications in Patients with LVADs
-
Mar 9, 2026, 16:30Mohamed Sikkander Abdul Razak: Recent Breakthroughs in Stem Cell Therapy for Diabetes Treatment
-
Mar 9, 2026, 16:28Augustina Isioma Ikusemoro: Is Blood Really Affordable?
-
Mar 9, 2026, 16:26Todd Maderis: Great Conversation on Effective Treatment of Chronic Infections
-
Mar 9, 2026, 16:25Denise Braendgaard: How Partnership is Turning Ambition Into Action
-
Mar 9, 2026, 16:10Veronica Sanchez: Recognizing the Risks of Preeclampsia During Pregnancy and Newly Postpartum
-
Mar 9, 2026, 16:06Abdul Mannan: Explaining the Molecular Mechanism Behind VITT
-
Mar 9, 2026, 16:03Wathsala Manindrani: Managing Severe Hypertriglyceridemia in Resource-Limited Settings
-
Mar 9, 2026, 15:55Honoring the Volunteers, Advocates, and Families Driving Awareness and Research of Glanzmann Thrombasthenia – GRF